trending Market Intelligence /marketintelligence/en/news-insights/trending/lhi5so0rq686ff3ntfiora2 content esgSubNav
In This List

Tonix Pharmaceuticals names board member

Blog

Insight Weekly: Bank boards lag on gender parity; future of office in doubt; US LNG exports leap

Blog

Insight Weekly: Job growth faces hurdles; shale firms sit on cash pile; Africa's lithium future

Blog

Insight Weekly: Loan growth picks up; US-China PE deals fall; France faces winter energy crunch

Blog

Perspectives from China: Chinese M&A in 2022


Tonix Pharmaceuticals names board member

New York-based Tonix Pharmaceuticals Holding Corp. appointed Adeoye Olukotun to its board.

He succeeds Ernest Mario, who stepped down as a director.

Olukotun is CEO of CR Strategies LLC, a clinical research and development consulting firm. His previous roles include CEO of EpiGen Pharmaceuticals Inc. and former vice chairman and CEO of CardioVax Inc.

Tonix Pharmaceuticals has two therapeutic programs focused on post-traumatic stress disorder.